The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
To own Kenvue, you need to believe in the resilience of its consumer health brands and the company’s ability to turn modest sales gains into durable earnings and cash generation. The latest quarterly results show higher sales and net income, but do not materially change the near term focus on integrating complexity across SKUs and channels, or the key risk that slow progress in e commerce and innovation could erode share against more digitally advanced rivals.
The recent 1.2 percent lift in the quarterly dividend to US$0.21 per share stands out in the context of rising earnings in the first half of 2026, reinforcing Kenvue’s stance on returning cash to shareholders even as it works through operational and portfolio challenges. For investors watching the earnings trend and the planned Kimberly Clark tie up, this dividend move links current profitability directly to shareholder income while the longer term execution story continues to unfold.
Yet alongside higher earnings and a slightly larger dividend, investors should still be aware of the risk that Kenvue’s underdeveloped e commerce presence could...
Read the full narrative on Kenvue (it's free!)
Kenvue's narrative projects $16.7 billion revenue and $2.3 billion earnings by 2029. This requires 2.9% yearly revenue growth and about a $0.7 billion earnings increase from $1.6 billion today.
Uncover how Kenvue's forecasts yield a $19.50 fair value, in line with its current price.
Three fair value estimates from the Simply Wall St Community span roughly US$19.50 to US$31.89, showing how widely individual views on Kenvue’s worth can differ. Against that backdrop, the recent earnings lift and dividend increase sit beside unresolved concerns about digital execution and brand relevance, which could influence how you weigh those differing valuations and the company’s future performance.
Explore 3 other fair value estimates on Kenvue - why the stock might be worth as much as 66% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com